Background: Whereas genetic susceptibility increases risk for major depressive disorder
Introduction
Exposure to stressful experiences is an important risk factor for major depressive disorder (MDD) (1)-however, not all individuals exposed to stressful experiences develop MDD. This observation is of high relevance for the US Army, whose soldiers routinely encounter stressful events over the course of combat deployment (2) and show a correspondingly high burden of MDD following deployment (3) (4) (5) . Preventing MDD and its associated disability and comorbidities can improve individual/family wellbeing and troop readiness (6) , and requires attention to risk and protective factors that influence depression.
The diathesis-stress model of depression (7) posits that some individuals have latent or pre-existing vulnerabilities, or diatheses, that are activated in the presence of stress to produce MDD. One such diathesis is genetic susceptibility, which has been found to substantially increase risk for MDD episodes in the presence of stressful life events (8) . Genetic susceptibility for a complex trait like MDD is thought to be polygenic-influenced by many common variants across the genome, each with relatively small effect sizes (9) . This influence can be indexed by polygenic risk scores (PRS) that combine effects across common variants using results from a discovery genome-wide association study (GWAS). For MDD, a well-powered GWAS with 461,134 individuals (10) has become available, and its derived PRS was recently validated in a diathesis-stress model for MDD in the context of life stressors (11) . However, to date, this PRS has not been prospectively validated in terms of new MDD onset following stress exposure.
While genetic susceptibility is a risk factor for depression, non-genetic protective factors may buffer this risk, illuminating opportunities for prevention. Protective factors can be specific to the individual (intrinsic) or related to the individual's environment (extrinsic) (12) . One intrinsic factor that has been studied in Army populations is trait resilience, defined as perceived hardiness to stress and ability to cope adaptively with stressors (13) . Unit cohesion-which includes emotional safety, bonding, and support between soldiers and with unit leaders-is an extrinsic factor that has also received substantial attention. Although these factors are well characterized for their protective effects on post-deployment mental health (14) (15) (16) (17) , the extent to which they attenuate risk for MDD in the presence of genetic susceptibility has not been examined.
The Army Study of Risk and Resilience in Servicemembers (Army STARRS) has followed a large prospective sample of active duty soldiers with genomic data across one combat deployment cycle (18) . This provides a unique opportunity to test the effects of genetic susceptibility and candidate protective factors assessed shortly before deployment, in relation to development of MDD following deployment. Specifically, we examine whether two putative protective factors-trait resilience (intrinsic) and unit cohesion (extrinsic)-can reduce risk for incident post-deployment MDD even among soldiers at high polygenic risk for MDD.
Methods

Participants and procedures
The Pre/Post Deployment Study (PPDS) in Army STARRS is a multi-wave panel survey of US Army soldiers from three brigade combat teams that were deployed to Afghanistan in 2012. Soldiers completed baseline assessments within approximately six weeks before deployment, and follow-up assessments at three and nine months post-deployment. For this analysis, the sample was restricted to those with eligible survey responses and samples for genotyping (N=4,900). Procedures for Army STARRS and PPDS have been reported in detail elsewhere (18, 19) . All participating soldiers provided written informed consent, and study procedures were approved by the institutional review boards at the Uniformed Services University of the Health Sciences, Harvard University, University of Michigan, and University of California, San Diego.
Measures
Major depressive disorder (MDD). MDD was ascertained at each assessment using items from the major depressive episode (MDE) scale of the WHO Composite International Diagnostic Interview-Screening Scales (CIDI-SC) (20) . Scale items assessed frequency of MDD symptoms (e.g., depressed mood, loss of interest) over the past 30 days, and were summed to yield overall symptom scores. Symptom scores were then dichotomized using receiver operating characteristic (ROC) curve analysis to determine clinical thresholds for past 30-day MDEs, as validated elsewhere (20) . Incident MDD was defined as no MDE at baseline, followed by a MDE at any point through nine months (0=no incident depression, 1=incident depression).
Soldiers who met criteria for an existing MDE at pre-deployment (N=310) or had no follow-up MDE data (N=408) were excluded since MDD incidence could not be established.
Trait resilience. Trait resilience was self-reported by soldiers at baseline using a fiveitem scale derived from a larger pool of 17 items that were pilot-tested in earlier Army STARRS surveys and culled using exploratory factor analysis and item response theory analysis for administration in the PPDS. Information on the development and validation of this scale has been published elsewhere (21) . Participants reported on their abilities to "keep calm and think of the right thing to do in a crisis," "manage stress," or to "try new approaches if old ones don't work" (all items described in Supplementary Materials S1A). Items were rated on a five-point Likert scale ranging from "poor" to "excellent," and summed to yield continuous scores ranging from 0 and 20. Internal consistency was good (α=0.89). Scores were standardized to a mean of 0 and variance of 1 for analysis. Items were rated on five-point Likert scale ranging from "strongly disagree" to "strongly agree,"
and were summed to yield continuous scores ranging between 0 and 27. Internal consistency was high (α=0.89); a factor analysis confirmed that one single factor was sufficient to represent shared variability among these seven scale items. Scores were standardized to a mean of 0 and variance of 1 for analysis.
Combat stress exposure. Within one month of return from deployment, soldiers also completed a 15-item measure of combat stress exposure-including engaging in combat patrol or other dangerous duties, and firing at and/or receiving enemy fire. These items were summed to reflect overall burden of combat stress exposure, as in previous research (19) .
DNA processing
Detailed information about genotyping, imputation, quality control (QC), and population assignment in Army STARRs is available elsewhere (23) . Briefly, DNA samples for each participant were genotyped using Illumina OmniExpress and Exome array with additional custom content. Initial quality control (QC) procedures were conducted to retain only (1) samples with genotype missingness < 0.02, no extreme autosomal heterozygosity, and no relatedness (if related pairs of individuals were identified, only one was kept); and (2) singlenucleotide polymorphisms (SNPs) with genotype missingness < 0.05 (before sample QC) and < 0.02 (after sample QC), minor allele frequency (MAF) > 0.05, and no violation of the HardyWeinberg equilibrium (p > 1x10 -6 ).
Prior to imputation, SNPs were also removed if they were not present or had nonmatching alleles in the 1000 Genomes Project reference panel (24) or had ambiguous alleles with MAF > 0.10. Following a two-step pre-phasing/imputation process (25) , imputed SNPs were converted to "best guess" genotyped SNPs based on their imputation probability. Where no possible genotype met the threshold of 80% probability, information for that SNP was set as missing. SNPs were filtered again to retain missingness < 0.02 and imputation quality (INFO) score > 0.80, and duplicate SNPs were identified for exclusion in subsequent analyses.
Ancestry was inferred through principal component (PC) analyses as reported previously (23) . Given that polygenic risk scores would be constructed using effect sizes obtained in samples of European ancestry (10), only PPDS participants assigned to the European ancestry (EA) group were retained for this study. By inspecting successive PC plots within the EA group for evidence of population structure, we determined only the first three principal components were likely relevant for inclusion as covariates in subsequent analyses.
Polygenic risk scoring
To construct the polygenic risk scores (PRS), we obtained summary statistics from the latest GWAS of MDD in 461,134 individuals (10). For main analyses, we used the set of summary statistics without 23andMe data (N=173,005) that is now publicly available. After removal of ambiguous SNPs, we clumped the GWAS summary statistics using our EA genomic data to limit inclusion of highly correlated SNPs, using a r 2 threshold of 0.25 and a 250kb
window. These clumped summary statistics were used to compute PRS from our EA genomic data that included SNPs whose effects met the following p-value thresholds (pT) in decreasing Table S2A) .
Statistical analyses
First, we examined the MDD PRS at varying p-value thresholds in relation to incident Figure S2A ). The PRS at the p-value threshold with largest Nagelkerke's pseudo-R 2 (pT=0.01) was selected for subsequent analyses (26) . This PRS was distributed across individuals and divided into three groups of polygenic risk (Supplementary (27) . Second, we used logistic regressions to examine the main effects of polygenic risk on incident MDD, using the low risk group as the reference group. Third, we used logistic regressions to examine the main effects of each protective factor on incident MDD. Fourth, we tested the effects of each protective factor (per standardized unit score) on incident MDD across polygenic risk groups. At each step, we adjusted for sex, age, and principal components to account for population stratification when polygenic scores were included. All analyses were conducted in R.
MDD (Supplementary Materials
Results
Sample characteristics
Our sample included PPDS participants of European ancestry who provided genomewide data, excluding soldiers with an existing MDE at pre-deployment or no follow-up MDE data (resulting N=4,182). The sample was predominantly (95%) male and younger than 30 years old (mean=26.0, SD=5.9). At baseline, soldiers tended to report high trait resilience scores and trait resilience (r=-0.01, p=0.62) were not significantly correlated with polygenic risk, ruling out the possibility that these factors were largely determined by genetic vulnerability for MDD.
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Does unit cohesion also protect against MDD after exposure to high environmental risk?
To further explore the protective effect of unit cohesion, we stratified soldiers by combat Table S2E ).
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Discussion
In this prospective study of US Army soldiers followed across their deployment to Afghanistan, we observed that polygenic risk was associated with incident MDD following deployment; however, an extrinsic protective factor-unit cohesion-showed robust protective effects for incident MDD even among soldiers at highest polygenic or environmental risk.
Our work makes a number of contributions to the literature. First, we capitalize on a unique, large-scale, prospectively studied cohort of individuals for whom both genomic data and rich phenotyping (including exposure to a defined class of stressors) are available, to answer key questions about risk and protective factors for MDD. While genetic and environmental factors are known to influence depression, we demonstrate for the first time that polygenic risk is prospectively associated with new-onset MDD. Second, we draw on the latest and largest GWAS of MDD (10) for polygenic scoring, and validate the resulting PRS as a diathesis for MDD.
Specifically, we show a dose-response relationship between polygenic risk and incident MDD following combat deployment, with a 52% increase in relative odds between soldiers in the top and bottom quintiles of polygenic risk. Thus, while PRS still account for modest variation in psychiatric traits, our main effect analyses indicate they can meaningfully explain increased risk for depression in our sample.
Third, we provide novel evidence that strong unit cohesion prior to deployment may buffer psychiatric risk regardless of underlying genetic susceptibility. Protective effects in the presence of high polygenic risk have been shown in cardiology (27) and we now apply this framework in psychiatry. While previous research has identified unit cohesion as a protective factor for mental health following deployment, most studies have been cross-sectional (16, 17, (28) (29) (30) (31) (32) and ours represents at least a four-fold increase in scale compared to existing prospective studies of unit cohesion and mental health (33, 34) , in addition to being the first to integrate genetic data. Fourth, we corroborate prior evidence that unit cohesion is associated with reduced risk for incident MDD despite high levels of combat stress exposure (28, (31) (32) (33) (34) and extend this to show that pre-deployment unit cohesion, combat stress exposure, and genetic susceptibility additively, and to some extent orthogonally, influence risk for incident MDD. This suggests that unit cohesion may be widely beneficial for soldiers despite genetic or environmental risk.
Unit cohesion has been conceptualized as a multi-faceted construct (35) In conclusion, our findings support a role for both genetic and environmental factors in influencing psychiatric risk in soldiers across combat deployment. In this prospective inquiry, we
showed that soldiers who experienced strong unit cohesion shortly before deployment were at reduced risk for incident MDD following deployment, regardless of their genetic susceptibility.
This study illustrates the potential of protective factors to buffer psychiatric risk following exposure to stressful events. Importantly, potentially actionable factors such as group cohesion and social support may protect against depression even among those most genetically susceptible, and represent promising targets for promoting resilience in at-risk populations. 
